Highlights
The global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) include Abbott Laboratories, Dexcom, GlySens Incorporated, Insulet Corp, Johnson & Johnson, Medtronic, Meiqi Medical Equipment, Microport and Roche, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM).
The Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott Laboratories
Dexcom
GlySens Incorporated
Insulet Corp
Johnson & Johnson
Medtronic
Meiqi Medical Equipment
Microport
Roche
Senseonics Holdings
SOOIL
Tandem Diabetes care
Segment by Type
Insulin Pump
Continuous Glucose Monitors (CGM)
Segment by Application
Child
Adult
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Overview
1.1 Product Overview and Scope of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
1.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Segment by Type
1.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Value Comparison by Type (2023-2029)
1.2.2 Insulin Pump
1.2.3 Continuous Glucose Monitors (CGM)
1.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Segment by Application
1.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Value by Application: (2023-2029)
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size Estimates and Forecasts
1.4.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2018-2029
1.4.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2018-2029
1.4.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Competition by Manufacturers
2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Average Price by Manufacturers (2018-2023)
2.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM), Product Type & Application
2.7 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Competitive Situation and Trends
2.7.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Players Market Share by Revenue
2.7.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Retrospective Market Scenario by Region
3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region: 2018-2029
3.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region: 2018-2023
3.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region: 2024-2029
3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region: 2018-2029
3.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region: 2018-2023
3.3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region: 2024-2029
3.4 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Facts & Figures by Country
3.4.1 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2018-2029)
3.4.3 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Facts & Figures by Country
3.5.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2018-2029)
3.5.3 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2018-2029)
3.6.3 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Facts & Figures by Country
3.7.1 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2018-2029)
3.7.3 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2018-2029)
4.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2018-2023)
4.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2024-2029)
4.1.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2018-2029)
4.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2018-2029)
4.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2018-2023)
4.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2024-2029)
4.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Type (2018-2029)
4.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2018-2029)
5.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2018-2023)
5.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2024-2029)
5.1.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2018-2029)
5.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2018-2029)
5.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2018-2023)
5.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2024-2029)
5.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Application (2018-2029)
5.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Dexcom
6.2.1 Dexcom Corporation Information
6.2.2 Dexcom Description and Business Overview
6.2.3 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.2.5 Dexcom Recent Developments/Updates
6.3 GlySens Incorporated
6.3.1 GlySens Incorporated Corporation Information
6.3.2 GlySens Incorporated Description and Business Overview
6.3.3 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.3.5 GlySens Incorporated Recent Developments/Updates
6.4 Insulet Corp
6.4.1 Insulet Corp Corporation Information
6.4.2 Insulet Corp Description and Business Overview
6.4.3 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.4.5 Insulet Corp Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 Meiqi Medical Equipment
6.6.1 Meiqi Medical Equipment Corporation Information
6.6.2 Meiqi Medical Equipment Description and Business Overview
6.6.3 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.7.5 Meiqi Medical Equipment Recent Developments/Updates
6.8 Microport
6.8.1 Microport Corporation Information
6.8.2 Microport Description and Business Overview
6.8.3 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.8.5 Microport Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Senseonics Holdings
6.10.1 Senseonics Holdings Corporation Information
6.10.2 Senseonics Holdings Description and Business Overview
6.10.3 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.10.5 Senseonics Holdings Recent Developments/Updates
6.11 SOOIL
6.11.1 SOOIL Corporation Information
6.11.2 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Description and Business Overview
6.11.3 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.11.5 SOOIL Recent Developments/Updates
6.12 Tandem Diabetes care
6.12.1 Tandem Diabetes care Corporation Information
6.12.2 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Description and Business Overview
6.12.3 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolio
6.12.5 Tandem Diabetes care Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industry Chain Analysis
7.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Production Mode & Process
7.4 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales and Marketing
7.4.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Channels
7.4.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Distributors
7.5 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Customers
8 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Dynamics
8.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industry Trends
8.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Drivers
8.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Challenges
8.4 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott Laboratories
Dexcom
GlySens Incorporated
Insulet Corp
Johnson & Johnson
Medtronic
Meiqi Medical Equipment
Microport
Roche
Senseonics Holdings
SOOIL
Tandem Diabetes care
听
听
*If Applicable.
